Bernard Siegel is the founder and Executive Director of Genetics Policy Institute (GPI), a nonprofit organization with offices in Palm Beach, Florida and Palo Alto, California. He is the founder and co-chair of a series of global conferences, including the annual World Stem Cell Summit and founder and editor-in-chief of the peer-reviewed World Stem Cell Report.
Mr. Siegel first became involved with the scientific community when, in 2002, he filed a landmark case seeking a guardian for the alleged clone, "Baby Eve." The case was widely credited for exposing Clonaid, the so-called "human cloning company" as a sham. This case, and the media attention which ensued, allowed Mr. Siegel to meet with scientists and policy experts to discuss the need for legal and policy advocates for the scientific community. This led to Mr. Siegel's founding of the Genetics Policy Institute and his commitment to advocacy work on behalf of patients, doctors and researchers involved with the regenerative medicine community
In 2003, he traded his 30-year courtroom career to found GPI and Stem Cell Action Coalition, which leads a global "Pro-Cures Movement." With the leadership of world-class advisory boards, GPI has filed briefs in federal litigation pertaining to stem cell funding and organized key meetings aimed at uniting the global stem cell community. In 2004, Mr. Siegel played a pivotal role in galvanizing a global movement that successfully lobbied the United Nations to reject a treaty that called for a prohibition of nuclear transfer, or therapeutic cloning.
As a recognized policy expert on stem cell research, regenerative medicine and cloning, Mr. Siegel works with the world's leading stem cell researchers and advocates. He works with grassroots activists throughout the United States, raising public awareness and educating lawmakers, the media and public on stem cells and regenerative medicine.
Mr. Siegel is a frequent panelist and keynote speaker on the subject of stem cells, public policy, patient advocacy and the societal implications of longevity. Among his many presentations, he has spoken at the United Nations, the Salk Institute, the German National Academy of Science (The Leopoldina), James Baker Institute of Public Policy at Rice University, Biotechnology Industry Organization (BIO), Diabetes Research Institute Foundation, Seoul National University, International Stem Cell Forum (Beijing), World Congress for Freedom of Scientific Research (Rome), Stem Cells Europe (Edinburgh, Amsterdam), World Stem Cells & Regenerative Medicine Congress (London), World Congress on Regenerative Medicine (Leipzig), ILSI BioMed (Tel Aviv), World Parkinson Congress, Association of American Law Schools and American College of Trial Lawyers. He has lectured at more than 40 colleges and universities around the globe.
Mr. Siegel frequently works with the media as a policy expert. His TV appearances include interviews with CBS Evening News, the CBS Early Show, CNN, CNN International, MSNBC, Fox and Friends, CNBC and network news shows throughout the U.S. and the world. He was profiled on National Public Radio's All Things Considered. His interviews appear in the journals Rejuvenation Research, Cell Stem Cell, Regenerative Medicine and Pharmaceutical Technology Europe. He has been quoted in the New York Times, The Washington Post, The Boston Globe, Wired News, The Scientist, New Scientist, The London Times, Le Monde, Pravda, The Peoples Daily and many other publications.
Mr. Siegel serves on the board of directors of the Coalition for Advancement of Medical Research (CAMR) and Americans for Cures Foundation. He also serves on the executive committee of the Alliance for Regenerative Medicine (ARM) and chaired that group's nominating committee. He is a past co-chair of the Governmental Affairs Committee of the International Society for Stem Cell Research (ISSCR).
At the University of Miami Miller School of Medicine, Mr. Siegel serves on the Governance Advisory Board of the Interdisciplinary Stem Cell Institute and as a member the Embryonic Stem Cell Research Oversight (ESCRO) Committee.
He serves on the advisory boards of the New England Regional Spinal Cord Injury Center at Boston Medical Center and Sabrina Cohen Foundation for Stem Cell Research. He is a member of the American Society for Bioethics + Humanities and the International Society for Cell Therapy. In addition, Mr. Siegel serves as a member of the Editorial Board of the award-winning, Medline-indexed journal, Regenerative Medicine.
He has published articles for the journals Cloning and Stem Cells, Burrill Stem Cell Report and the World Stem Cell Report. His Opinion Editorials have appeared in the Baltimore Sun, Sun-Sentinel, Palm Beach Post, Tallahassee Democrat, Detroit News and Genetic Engineering and Biotechnology News.
His honors include the 2005 Advocacy Award from the Stem Cell Action Network. Mr. Siegel was voted one of the "dLife Top 10" individuals who made the greatest contribution to the lives of people with diabetes in 2006. In 2009, the City of Palm Springs, California; Miami-Dade County, Florida; and Baltimore, Maryland issued public proclamations applauding Bernard Siegel's efforts on behalf of the global stem cell community. Mr. Siegel was ranked number 22 in the 2013 ranking of the "Top 50 Global Stem Cell Influencers."
A native of Richmond, Virginia, he received his undergraduate and law degrees from the University of Miami (BA 1972, JD 1975). He is a member of the Florida Bar, since 1975.
The Genetics Policy Institute